Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer|April 3, 2007
The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinomaEric D Tetzlaff, Arlene M Correa, Jackie Baker, et al.Work (Reading, Mass.)|October 29, 2019
Shelter dogs, university employees, and lunchtime walks: A pilot studyMelanie L Sartore-Baldwin, Jackie Baker, Lacey Schwab, et al.Cancer|March 29, 2006
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 studyJaffer A Ajani, J Randolph Hecht, Linus Ho, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|May 27, 2008
Docetaxel-related side effects and their managementJackie Baker, Jaffer Ajani, Florian Scotté, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 10, 2009
Docetaxel-related side effects and their managementJackie Baker, Jaffer Ajani, Florian Scotté, et al.Oncology (Williston Park, N.Y.)|July 12, 2002
Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinomaJaffer A Ajani, Jackie Baker, Peter W Pisters, et al.Cancer|February 22, 2002
CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II studyJaffer A Ajani, Jackie Baker, Peter W T Pisters, et al.American Journal of Clinical Oncology|February 25, 2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal JunctionMariela A Blum Murphy, Wei Qiao, Nishith Mewada, et al.Oncology|October 23, 2015
Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid MalignanciesRastislav Bahleda, Jackie Baker, Christophe Massard, et al.Annals of Surgical Oncology|March 8, 2007
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junctionKazumasa Fujitani, Jaffer A Ajani, Christopher H Crane, et al.Pageof 1